Soleno Therapeutics (SLNO) Net Income (QoQ) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Soleno Therapeutics | 2.76 Bn | 2.51 Bn | 93.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -27.63% |
| Dec 31, 2025 | 66.68% |
| Sep 30, 2025 | 652.53% |
| Jun 30, 2025 | 89.24% |
| Mar 31, 2025 | 21.48% |
| Dec 31, 2024 | 27.23% |
| Sep 30, 2024 | -250.58% |
| Jun 30, 2024 | -2.13% |
| Mar 31, 2024 | -81.86% |
| Dec 31, 2023 | -15.26% |
| Sep 30, 2023 | -20.43% |
| Jun 30, 2023 | -1.44% |
| Mar 31, 2023 | -48.95% |
| Dec 31, 2022 | 10.02% |
| Sep 30, 2022 | 8.02% |
| Jun 30, 2022 | -17.43% |
| Mar 31, 2022 | -92.37% |
| Dec 31, 2021 | 63.78% |
| Sep 30, 2021 | 25.25% |
| Jun 30, 2021 | -21.07% |
| Mar 31, 2021 | -15.07% |
| Dec 31, 2020 | -1.27% |
| Sep 30, 2020 | 29.80% |
| Jun 30, 2020 | -20.59% |
| Dec 31, 2018 | 69.56% |
| Sep 30, 2018 | -0.95% |
| Jun 30, 2018 | 17.70% |
| Mar 31, 2018 | 83.89% |
| Dec 31, 2017 | -146.60% |
| Sep 30, 2017 | -41.73% |
| Jun 30, 2017 | -8.43% |
| Mar 31, 2017 | 29.34% |
| Dec 31, 2016 | -22.47% |
| Sep 30, 2016 | 15.10% |
| Jun 30, 2016 | 73.12% |
| Mar 31, 2016 | -21.60% |
| Dec 31, 2015 | -10.14% |
| Sep 30, 2015 | -4.57% |
| Jun 30, 2015 | -25.42% |
| Mar 31, 2015 | 41.74% |
| Dec 31, 2014 | -100.77% |
| Sep 30, 2014 | -4.96% |
| Jun 30, 2014 | -84.42% |
| Mar 31, 2014 | -23.32% |
| Dec 31, 2013 | 44.42% |